Exam 7 L. 4 Flashcards
Primary hemostasis
The formation of the platelet plug
-sufficient for small vessel injury
Secondary hemostasis
The formation of the fibrin clot through the coagulation cascade
-fibrin clot is needed for medium/large vessels
Tertiary hemostasis
Fibrinolysis to reestablish blood flow through vessels
Normal vessel
Platelet adhesion prevented by:
- negatively charged endothelium (repels platelets)
- nitric oxide
- prostacyclin
- ADPase
Endothelial damage
1) vasoconstriction: platelets are slowed, giving them time to interact with subendothelium
2) subendothelium exposed: vWF visible
3) platelets tether to vWF ==> activates platelets to bind to fibrinogen
- fibrinogen allows platelets to bind together
4) activated platelets attract and activate more platelets (ADP and Thromboxane A2)
5) activated platelets set the stage for secondary hemostasis (provide docking site for clotting factors need)
What can go wrong with primary hemostasis?
1) platelet: function and number
2) von Willebrand factor: number and function
Primary hemostatic disorders
1) thrombocytopenia
- use, destruction, decreased production
2) acquired
- immune mediated, infectious disease, DIC, drugs
- thrombocytopenia is the most common acquired disorder of primary hemostasis!!
Primary hemostatic disorder: von Willebrand’s disease
Inherited: Doberman!
-Most common inherited primary hemostatic disorder is von Willebrand’s disease!**
Platelet count
1) estimate from a blood smear
- 1 per 100x field = 20,000 platelets/ul
- check the feathered edge!!
- A normal dog has between 8 to 10 platelets per high-powered field
2) spontaneous bleeding will not occurring last count is under 30,000 platelets/ul
How do you test platelet function?
1) Buccal mucosal bleeding time
- a test for a defect in primary hemostasis
- makes an incision of standard depth and width in buccal mucosa
2) will be abnormal (>4 minutes) if:
- thrombocytopenic, thrombopathic, vWF deficient/abnormal, abnormal vasculature
Immune-mediated thrombocytopenia (ITP)
1) can be primary or secondary
2) secondary: drugs, infectious agents (especially vectorborne diseases), neoplasia
- for some reason there is antibody versus platelets, and macrophages are gobbling up the platelets
Treatment for ITP
1) Vincristine
- a 1 time shot! (It works or it doesn’t)
- prevents microtubule polymerization
- accelerated megakaryocyte fragmentation and platelet release from bone marrow
- no place for vincristine in IMHA treatment
When to transfuse platelets?
1) Severe thrombocytopenia
2) suspect pulmonary or CNS hemorrhage
3) acquired or hereditary thrombopathia
What products contain viable platelets??
1) fresh whole blood
2) platelet rich plasma
- generated from a soft spin of blood
3) platelet concentrate (fresh or cryopreserved)
- PRP that has been spun hard to concentrate platelets
ITP prognosis
1) good!
2) 10-30% mortality rate
3) like IMHA, does require long-term immunosuppressive therapy